Dr. Neal Eigler, Chief Executive Officer at V-Wave, said: “As an interventional cardiologist focused on HF for the past two decades, I am excited that with this funding, we can pursue the science that will bring us a giant step closer to commercial release of an easy to implant device that can provide the hope for immediate and longer-term symptom relief, increased exercise capacity, decreased need for acute hospital admission, and reduced mortality with an improved quality of life for hundreds of thousands of suffering patients.”
About V-Wave Ltd.
V-Wave is a privately held medical device company with offices in Israel and the U.S.
Ad Statistics
Times Displayed: 22195
Times Visited: 440 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
About Deerfield
Deerfield is an investment management firm committed to advancing healthcare through investment, information and philanthropy.
About Endeavour Vision
Endeavour Vision is a global investor in exceptional medtech companies, led by extraordinary teams, working on big ideas with the potential to meaningfully improve the standard of care.
About Quark Venture
Quark Venture Inc., headquartered in Vancouver, Canada, is focused on equity financing of innovative biotechnology and health sciences companies with breakthrough technology platforms and projects.
About Aperture Venture Partners
Aperture Venture Partners is a healthcare-focused investment firm committed to working with exceptional entrepreneurs to build innovative companies in the medical device, pharmaceutical, healthcare IT/services and diagnostic sectors.
Back to HCB News
